• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过破坏E-钙黏蛋白实现肿瘤细胞解离来切除低位结直肠肿瘤

Low Colorectal Tumor Removal by E-Cadherin Destruction-Enabled Tumor Cell Dissociation.

作者信息

Li Man, Bao Qunqun, Guo Jing, Xie Ruting, Shen Chao, Wei Qing, Hu Ping, Qin Huanlong, Shi Jianlin

机构信息

Shanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, School of Medicine, Tongji University, Shanghai, 200072, P.R. China.

Department of Pathology, Shanghai Tenth People's Hospital, 301 Yan-chang Road, Shanghai 200072, P. R. China.

出版信息

Nano Lett. 2022 Apr 13;22(7):2769-2779. doi: 10.1021/acs.nanolett.1c04797. Epub 2022 Mar 25.

DOI:10.1021/acs.nanolett.1c04797
PMID:35333538
Abstract

Treatments for low colorectal cancer (CRC) remain a great challenge due to the heavy physical and psychological burdens of colostomy, strong drug toxicity in chemotherapy, and myelosuppression-/chemoradiation-related gastrointestinal symptoms. In this study, a highly biosafe and effective tumor cell dissociation-based low CRC treatment modality has been verified on both PDOs and colorectal tumor models . Notably, controllable EDTA release at the tumor sites was achieved by the LDH degradation in response to a slightly acidic microenvironment of low CRC tumors. Resultantly, the intratumoral E-cadherin for intercellular junctions of low CRC tumors was effectively destroyed via Ca depletion by released EDTA from the interlayers, initiating remarkable tumor cell dissociation and resultant tumor disaggregation/removal via defecation. Dissociated tumor cells were prevailingly enveloped by LDH/EDTA, which prevented them from readhering to adjacent tissues, providing an unprecedented, efficient and safe therapeutic modality for low CRC, which will benefit patients suffering low CRC.

摘要

由于结肠造口术带来的沉重身心负担、化疗中强烈的药物毒性以及骨髓抑制和放化疗相关的胃肠道症状,低位结直肠癌(CRC)的治疗仍然是一个巨大的挑战。在本研究中,一种基于肿瘤细胞解离的高度生物安全且有效的低位CRC治疗模式已在患者来源的肿瘤组织(PDO)和结直肠肿瘤模型上得到验证。值得注意的是,通过层状双氢氧化物(LDH)在低位CRC肿瘤微酸性环境下的降解,实现了肿瘤部位可控的乙二胺四乙酸(EDTA)释放。结果,通过层间释放的EDTA导致的钙耗竭,低位CRC肿瘤细胞间连接的肿瘤内E-钙黏蛋白被有效破坏,引发显著的肿瘤细胞解离,并通过排便导致肿瘤解体/清除。解离的肿瘤细胞主要被LDH/EDTA包裹,这阻止了它们重新黏附到相邻组织,为低位CRC提供了一种前所未有的、高效且安全的治疗模式,这将使患有低位CRC的患者受益。

相似文献

1
Low Colorectal Tumor Removal by E-Cadherin Destruction-Enabled Tumor Cell Dissociation.通过破坏E-钙黏蛋白实现肿瘤细胞解离来切除低位结直肠肿瘤
Nano Lett. 2022 Apr 13;22(7):2769-2779. doi: 10.1021/acs.nanolett.1c04797. Epub 2022 Mar 25.
2
Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma.真核生物翻译起始因子4E、血管内皮生长因子-C、E-钙黏蛋白和基质金属蛋白酶-2在结直肠癌中的表达分析及临床意义
Oncotarget. 2016 Dec 20;7(51):85502-85514. doi: 10.18632/oncotarget.13453.
3
N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.N-钙黏蛋白是一种新型的预后生物标志物,可驱动结直肠癌的恶性进展。
Mol Med Rep. 2015 Aug;12(2):2999-3006. doi: 10.3892/mmr.2015.3687. Epub 2015 Apr 27.
4
Epigenetic suppression of E-cadherin expression by Snail2 during the metastasis of colorectal cancer.Snail2 通过表观遗传抑制结直肠癌细胞转移过程中 E-钙黏蛋白的表达。
Clin Epigenetics. 2018 Dec 12;10(1):154. doi: 10.1186/s13148-018-0592-y.
5
The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.溴结构域PHD指转录因子在结直肠癌中的预后意义及其与波形蛋白和E-钙黏蛋白的关系
J Cancer Res Clin Oncol. 2015 Aug;141(8):1465-74. doi: 10.1007/s00432-015-1937-y. Epub 2015 Feb 26.
6
Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.钙黏蛋白-12增强结肠癌细胞的增殖,并通过促进上皮-间质转化增加肿瘤进展。
Tumour Biol. 2016 Jul;37(7):9077-88. doi: 10.1007/s13277-015-4555-z. Epub 2016 Jan 14.
7
Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.生长抑制因子4通过诱导G1期阻滞、抑制肿瘤血管生成和逆转上皮-间质转化来抑制结直肠癌的生长和侵袭。
Oncol Rep. 2016 May;35(5):2927-35. doi: 10.3892/or.2016.4626. Epub 2016 Feb 18.
8
SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.生物信息学分析表明,SPP1 通过激活 EMT 通路促进结直肠癌转移。
Biomed Pharmacother. 2017 Jul;91:1167-1177. doi: 10.1016/j.biopha.2017.05.056. Epub 2017 May 17.
9
Cadherin-12 contributes to tumorigenicity in colorectal cancer by promoting migration, invasion, adhersion and angiogenesis.钙黏蛋白-12通过促进迁移、侵袭、黏附和血管生成,在结直肠癌的致瘤性中发挥作用。
J Transl Med. 2013 Nov 15;11:288. doi: 10.1186/1479-5876-11-288.
10
Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.评估肿瘤细胞解离作为黏膜下浸润性结直肠癌淋巴结转移预测标志物的研究
Dis Colon Rectum. 2005 May;48(5):938-45. doi: 10.1007/s10350-004-0883-6.

引用本文的文献

1
Calcium-based biomaterials: Unveiling features and expanding applications in osteosarcoma treatment.钙基生物材料:揭示其特性并拓展在骨肉瘤治疗中的应用
Bioact Mater. 2023 Oct 22;32:385-399. doi: 10.1016/j.bioactmat.2023.10.008. eCollection 2024 Feb.
2
Hypoxia-responsive Immunostimulatory Nanomedicines Synergize with Checkpoint Blockade Immunotherapy for Potentiating Cancer Immunotherapy.缺氧响应性免疫刺激纳米药物与检查点阻断免疫疗法协同作用以增强癌症免疫治疗
Chem Eng J. 2023 Jan;451(Pt 2). doi: 10.1016/j.cej.2022.138781. Epub 2022 Aug 24.
3
Functional Nanoparticles for Enhanced Cancer Therapy.
用于增强癌症治疗的功能性纳米颗粒
Pharmaceutics. 2022 Aug 12;14(8):1682. doi: 10.3390/pharmaceutics14081682.